Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 11(1): 7672, 2021 04 07.
Artículo en Inglés | MEDLINE | ID: mdl-33828221

RESUMEN

Zoledronic acid (ZA) is often prescribed for osteoporosis or resorptive metabolic bone disease. This study aims to evaluate the effect of ZA on orthodontic tooth movement (OTM) and root and bone resorption and its repercussion on root, periodontal ligament and alveolar bone tissues. The experimental group consisted of 72 Wistar rats divided in four subgroups: Naive, Saline and Zoledronic Acid groups at the concentration of 0.2 mg/kg [ZA (0.2)] or 1.0 mg/kg [ZA (1.0)]. The animals were subjected to i.v (dorsal penile vein) administrations of ZA or saline solution, on days 0, 7, 14 and 42. Under anesthesia, NiTi springs were installed in the first left maxillary molar with 50gf allowing the OTM, except for the negative control group (N) for mesial movement of the left first maxillary teeth. The animals were sacrificed and maxillae were removed for macroscopic and histopathological analyzes, scanning electron microscopy, computerized microtomography and confocal microscopy. Treatment with ZA decreased the OTM and the number of osteoclasts and loss of alveolar bone when compared to the naive and saline groups. Reduction of radicular resorption, increased necrotic areas and reduced vascularization in the periodontal ligament were observed in the ZA groups. ZA interferes with OTM and presents anti-resorptive effects on bone and dental tissues associated with a decreased vascularization, without osteonecrosis.


Asunto(s)
Proceso Alveolar/efectos de los fármacos , Conservadores de la Densidad Ósea/efectos adversos , Ligamento Periodontal/efectos de los fármacos , Técnicas de Movimiento Dental , Raíz del Diente/efectos de los fármacos , Ácido Zoledrónico/efectos adversos , Animales , Conservadores de la Densidad Ósea/administración & dosificación , Resorción Ósea/prevención & control , Evaluación Preclínica de Medicamentos , Masculino , Osteoporosis/tratamiento farmacológico , Ratas Wistar , Ácido Zoledrónico/administración & dosificación
2.
Food Res Int ; 99(Pt 2): 959-968, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28847433

RESUMEN

This study investigated the anti-inflammatory activity of the extract (LEG) and purified (LPG) lycopene from guava (Psidium guajava L.), as well as some mechanisms possibly involved in this effect. The anti-inflammatory activity was initially assessed using paw edema induced by Carrageenan, Dextran, Compound 48/80, Histamine and Prostaglandin E2 in Swiss mice. A peritonitis model was used to evaluate neutrophil migration, the activity of myeloperoxidase (MPO) and reduced glutathione (GSH) concentration; while the effect on the expression of iNOS, COX-2 and NF-κB, was assessed by immunohistochemistry analysis. Results showed that oral and intraperitoneal administration of LEG and LPG inhibited inflammation caused by carrageenan. LPG (12.5mg/kg p.o.) significantly inhibited the edema formation induced by different phlogistic agents and immunostaining for iNOS, COX-2 and NF-κB. Leukocytes migration in paw tissue and peritoneal cavity was reduced, as well as MPO concentration, whereas GSH levels increased. Thus, lycopene-rich extract from red guava has beneficial effect on acute inflammation, offering protection against the consequences of oxidative stress by downregulating inflammatory mediators and inhibiting gene expression involved in inflammation.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Edema/prevención & control , Inflamación/prevención & control , Leucocitos/efectos de los fármacos , Peritonitis/prevención & control , Extractos Vegetales/farmacología , Psidium , Animales , Antiinflamatorios/aislamiento & purificación , Antioxidantes/aislamiento & purificación , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Edema/inmunología , Edema/metabolismo , Femenino , Frutas , Glutatión/metabolismo , Inflamación/inmunología , Inflamación/metabolismo , Mediadores de Inflamación/metabolismo , Leucocitos/inmunología , Leucocitos/metabolismo , Masculino , Ratones , FN-kappa B/metabolismo , Infiltración Neutrófila/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Estrés Oxidativo/efectos de los fármacos , Peritonitis/inmunología , Peritonitis/metabolismo , Peroxidasa/metabolismo , Extractos Vegetales/aislamiento & purificación , Psidium/química
3.
Arch Oral Biol ; 74: 63-68, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27883909

RESUMEN

OBJECTIVE: To evaluate the anti-inflammatory effect of pretreatment for three days with a fatty acid mixture with high ω-9:ω-6 ratio and low ω-6:ω-3 ratio on rats submitted to dental extraction. MATERIAL AND METHODS: Thirty-two male Wistar rats (270-310g) were randomly distributed in four groups (n=8/group): the sham control group and the negative control group received saline; the high omega-6/low omega-9 group received isolipid fatty acid with high ω-6:ω-3 ratio and low ω-9:ω-6 ratio; the high omega-3/low omega-6 group received fatty acid with low ω-6:ω-3 ratio and high ω-9:ω-6 ratio. Saline and oils were administered by gavage for 4days before exodontia and 3days after surgery, followed by euthanasia. Masseter edema was evaluated clinically and tissue samples were submitted to osteoclast count (H&E), myeloperoxidase assay, and western blotting (tumor necrosis factor-alpha and interleukin-1beta). RESULTS: In the high omega-3/low omega-6 group, a significant decrease was observed in masseter edema (p<0.0001), myeloperoxidase (p<0.0001), osteoclasts (p=0.0001) and TNF-α expression (p<0.0001), but not in IL-1ß expression. CONCLUSION: The ingestion of fatty acid with high ω-9:ω-6 ratio and low ω-6:ω-3 ratio significantly reduced inflammatory response in rats submitted to dental extraction.


Asunto(s)
Antiinflamatorios/farmacología , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Omega-6/farmacología , Ácidos Grasos/farmacología , Extracción Dental/métodos , Animales , Combinación de Medicamentos , Edema/tratamiento farmacológico , Interleucina-1beta/análisis , Masculino , Osteoclastos/efectos de los fármacos , Peroxidasa/análisis , Ratas , Ratas Wistar , Factores de Tiempo , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/análisis , Cicatrización de Heridas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA